Evolution of the management of malignant ventricular tachyarrhythmias: The roles of drug therapy and implantable defibrillators
Open Access
- 30 November 1995
- journal article
- editorial
- Published by Elsevier in American Heart Journal
- Vol. 130 (5) , 1144-1150
- https://doi.org/10.1016/0002-8703(95)90224-4
Abstract
No abstract availableThis publication has 45 references indexed in Scilit:
- Influence of left ventricular function on survival and mode of death after implantable defibrillator therapy (Cleveland Clinic Foundation and Montefiore Medical Center experience)The American Journal of Cardiology, 1993
- A Comparison of Seven Antiarrhythmic Drugs in Patients with Ventricular TachyarrhythmiasNew England Journal of Medicine, 1993
- A Comparison of Electrophysiologic Testing with Holter Monitoring to Predict Antiarrhythmic-Drug Efficacy for Ventricular TachyarrhythmiasNew England Journal of Medicine, 1993
- Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE study)The American Journal of Cardiology, 1993
- Radiofrequency catheter ablation of ventricular tachycardia in patients with coronary artery disease.Circulation, 1993
- Effect of amiodarone on mortality after myocardial infarction: A double-blind, placebo-controlled, pilot studyJournal of the American College of Cardiology, 1992
- Radiofrequency catheter ablation of ventricular tachycardia in patients without structural heart disease.Circulation, 1992
- Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial InfarctionNew England Journal of Medicine, 1989
- Long-term outcome with the automatic implantable cardioverter-defibrillatorJournal of the American College of Cardiology, 1989
- Termination of Malignant Ventricular Arrhythmias with an Implanted Automatic Defibrillator in Human BeingsNew England Journal of Medicine, 1980